Engineering of HBsAg Antigen Containing Poly (ε- Caprolactone) Microspheres to Tailor Particle Size

Vivek Shrivastava; U. K. Jain

Vivek Shrivastava Bhopal Institute of Technology and Sciences- Pharmacy, Bhopal
U. K. Jain Bhopal Institute of Technology and Sciences- Pharmacy, Bhopal

Abstract

The aim of this work was to optimize particle size of Hepatitis B Surface (HBsAg) antigen containing poly(ε-caprolactone) (PCL) microspheres using the water-in-oil-in water solvent evaporation technique. Effects of manufacturing and formulation variables on particle size were investigated. It was observed that microsphere size could be controlled by modification of PCL concentration in the organic phase, polyvinyl alcohol (PVA) concentration in the outer aqueous phase, HBsAg concentration in inner aqueous phase, organic phase volume, and sonication time for primary w/o emulsion preparation. The optimized conditions yielded microspheres with an average particle size of 7.34 μm. Such biodegradable PCL microspheres appear suitable for the use as vaccine adjuvant.

Keywords: Microspheres, HBsAg, Poly(ε-caprolactone), Polyvinyl alcohol

References

1. Singh M, O’Hagan DT. Recent Advances in Vaccine Adjuvants. Pharmaceutical Research. 2002; 19(6): 715-27.
2. O’Hagan DT, Valiante N. Recent advances in the discovery and delivery of vaccine adjuvants. Nat. Rev. Drug Discov. 2003; 2(9): 727-35.
3. Parikh RH, Parikh JR, Dubey RR, Soni HN, Kapadia KN. Development of biodegradable starch microspheres for intranasal delivery AAPS PharmSciTech. 2003; 4(2): 1-8.
4. Saravanakumar A, Minz S, Pradhan M, Sure P, Chandu AN, Mishra U, Kamalakannan K, Sivakumar T. Polylactic Acid Microspheres as A Potential Vaccine Delivery System for the Tetanus Toxoid: Preparation and In Vitro Dissolution Study Research J Pharm and Tech. 2008; 1(4): 453-9.
5. Birnbaum DT, Kosmala JD, Peppas LB. Preparation and Characterization of Repaglinide Loaded Chitosan Polymeric Nanoparticles Journal of Nanoparticle Research 2000; 2: 173–81.
6. Ito F, Fujimori H, Makinoa K. Preparation and properties of PLGA microspheres containing hydrophilic drugs by the SPG (shirasu porous glass) membrane emulsification technique. Biointerfaces 2008; 61: 25-9.
7. Shameem M, Lee H, DeLuca PP. Antioxidant capacity, anticancer effects and absorption of mango(mangifera indica L.) polyphenols in vitro; AAPS Pharmsci 1999; 1(3): 131-6.
8. Berchane NS, Jebrail FF, Andrews M.J. Optimization of PLG microspheres for tailored drug release.International Journal of Pharmaceutics 2010; 383: 81- 8.
9. Yi-Yan Yang YY, Chung TS, Bai XL, Chan WK. POE–PEG–POE triblock copolymeric microspheres containing protein: I. Preparation and characterization Chemical Engineering Science (2000) 55.
10. Iyer S, Robinett RSR, HogenEsch H, Hem SL. A heat-stable hepatitis B vaccine formulation Vaccine 2004; 22: 1475-9.